113 related articles for article (PubMed ID: 38807374)
61. Amlexanox Suppresses Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss.
Zhang Y; Guan H; Li J; Fang Z; Chen W; Li F
Sci Rep; 2015 Sep; 5():13575. PubMed ID: 26338477
[TBL] [Abstract][Full Text] [Related]
62. Silencing Proteasome 26S Subunit ATPase 2 (PSMC2) Protects the Osteogenic Differentiation In Vitro and Osteogenesis In Vivo.
Zhou B; Peng K; Wang G; Chen W; Kang Y
Calcif Tissue Int; 2021 Jul; 109(1):44-54. PubMed ID: 33625534
[TBL] [Abstract][Full Text] [Related]
63. Dioscin reduces ovariectomy-induced bone loss by enhancing osteoblastogenesis and inhibiting osteoclastogenesis.
Tao X; Qi Y; Xu L; Yin L; Han X; Xu Y; Wang C; Sun H; Peng J
Pharmacol Res; 2016 Jun; 108():90-101. PubMed ID: 27155058
[TBL] [Abstract][Full Text] [Related]
64. Pseurotin A Inhibits Osteoclastogenesis and Prevents Ovariectomized-Induced Bone Loss by Suppressing Reactive Oxygen Species.
Chen K; Qiu P; Yuan Y; Zheng L; He J; Wang C; Guo Q; Kenny J; Liu Q; Zhao J; Chen J; Tickner J; Fan S; Lin X; Xu J
Theranostics; 2019; 9(6):1634-1650. PubMed ID: 31037128
[No Abstract] [Full Text] [Related]
65. Conjugated linoleic Acid prevents ovariectomy-induced bone loss in mice by modulating both osteoclastogenesis and osteoblastogenesis.
Rahman MM; Fernandes G; Williams P
Lipids; 2014 Mar; 49(3):211-24. PubMed ID: 24338525
[TBL] [Abstract][Full Text] [Related]
66. Interleukin-7 influences osteoclast function in vivo but is not a critical factor in ovariectomy-induced bone loss.
Lee SK; Kalinowski JF; Jacquin C; Adams DJ; Gronowicz G; Lorenzo JA
J Bone Miner Res; 2006 May; 21(5):695-702. PubMed ID: 16734384
[TBL] [Abstract][Full Text] [Related]
67. Acacetin Prevents Bone Loss by Disrupting Osteoclast Formation and Promoting Type H Vessel Formation in Ovariectomy-Induced Osteoporosis.
Lin X; Xu F; Zhang KW; Qiu WX; Zhang H; Hao Q; Li M; Deng XN; Tian Y; Chen ZH; Qian AR
Front Cell Dev Biol; 2022; 10():796227. PubMed ID: 35517504
[TBL] [Abstract][Full Text] [Related]
68. High-mobility group box chromosomal protein-1 deletion alleviates osteoporosis in OVX rat model via suppressing the osteoclastogenesis and inflammation.
Yu H; Zhou W; Zhong Z; Qiu R; Chen G; Zhang P
J Orthop Surg Res; 2022 Apr; 17(1):232. PubMed ID: 35414033
[TBL] [Abstract][Full Text] [Related]
69. Interferon Regulatory Factor 4 (IRF4) Plays a Key Role in Osteoblast Differentiation of Postmenopausal Osteoporosis.
Wu X; Yang C; Chen X; Shan Z; Wu X
Front Biosci (Landmark Ed); 2024 Mar; 29(3):115. PubMed ID: 38538259
[TBL] [Abstract][Full Text] [Related]
70. Piezoelectric Microvibration Mitigates Estrogen Loss-Induced Osteoporosis and Promotes Piezo1, MicroRNA-29a, and Wnt3a Signaling in Osteoblasts.
Wu RW; Lian WS; Chen YS; Ko JY; Wang SY; Jahr H; Wang FS
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502380
[TBL] [Abstract][Full Text] [Related]
71. Pulsed electromagnetic fields (PEMF) attenuate changes in vertebral bone mass, architecture and strength in ovariectomized mice.
Lei T; Liang Z; Li F; Tang C; Xie K; Wang P; Dong X; Shan S; Jiang M; Xu Q; Luo E; Shen G
Bone; 2018 Mar; 108():10-19. PubMed ID: 29229438
[TBL] [Abstract][Full Text] [Related]
72. Siglec-15 is a potential therapeutic target for postmenopausal osteoporosis.
Kameda Y; Takahata M; Mikuni S; Shimizu T; Hamano H; Angata T; Hatakeyama S; Kinjo M; Iwasaki N
Bone; 2015 Feb; 71():217-26. PubMed ID: 25460183
[TBL] [Abstract][Full Text] [Related]
73. Macrolactin F inhibits RANKL-mediated osteoclastogenesis by suppressing Akt, MAPK and NFATc1 pathways and promotes osteoblastogenesis through a BMP-2/smad/Akt/Runx2 signaling pathway.
Li L; Sapkota M; Gao M; Choi H; Soh Y
Eur J Pharmacol; 2017 Nov; 815():202-209. PubMed ID: 28919027
[TBL] [Abstract][Full Text] [Related]
74. Emodin regulates bone remodeling by inhibiting osteoclastogenesis and stimulating osteoblast formation.
Kim JY; Cheon YH; Kwak SC; Baek JM; Yoon KH; Lee MS; Oh J
J Bone Miner Res; 2014 Jul; 29(7):1541-53. PubMed ID: 25832436
[TBL] [Abstract][Full Text] [Related]
75. Pharmacological inhibition of protein S-palmitoylation suppresses osteoclastogenesis and ameliorates ovariectomy-induced bone loss.
Ma L; Zhang L; Liao Z; Xiu C; Luo X; Luo N; Zhang L; He G; Chen J
J Orthop Translat; 2023 Sep; 42():1-14. PubMed ID: 37521493
[TBL] [Abstract][Full Text] [Related]
76. Ulmus macrocarpa Hance trunk bark extracts inhibit RANKL-induced osteoclast differentiation and prevent ovariectomy-induced osteoporosis in mice.
Jeong C; Lee CH; Lee Y; Seo J; Wang W; Park KH; Oh E; Cho Y; Park C; Son YJ; Yoon Park JH; Kang H; Lee KW
J Ethnopharmacol; 2024 Jan; 319(Pt 3):117285. PubMed ID: 37839769
[TBL] [Abstract][Full Text] [Related]
77. Muramyl dipeptide alleviates estrogen deficiency-induced osteoporosis through canonical Wnt signaling.
Park OJ; Kwon Y; Kim J; Park C; Yun CH; Han SH
J Pathol; 2023 Jun; 260(2):137-147. PubMed ID: 36811349
[TBL] [Abstract][Full Text] [Related]
78. Biglycan deficiency interferes with ovariectomy-induced bone loss.
Nielsen KL; Allen MR; Bloomfield SA; Andersen TL; Chen XD; Poulsen HS; Young MF; Heegaard AM
J Bone Miner Res; 2003 Dec; 18(12):2152-8. PubMed ID: 14672350
[TBL] [Abstract][Full Text] [Related]
79. Effect of Zuoguiwan on osteoporosis in ovariectomized rats through RANKL/OPG pathway mediated by β2AR.
Liu F; Tan F; Tong W; Fan Q; Ye S; Lu S; Teng Z; Han M; Zhang M; Chai Y
Biomed Pharmacother; 2018 Jul; 103():1052-1060. PubMed ID: 29710663
[TBL] [Abstract][Full Text] [Related]
80. Aikeqing, a kidney- and spleen-tonifying compound Chinese medicine granule, prevented ovariectomy-induced bone loss in rats via the suppression of osteoclastogenesis.
Liu ZW; Xi XL; Wu TR; Lu YY; Zhong PC; Hu YJ; Shen XL
Biomed Pharmacother; 2023 Oct; 166():115339. PubMed ID: 37595429
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
